Update on Immunization Programme and Pandemic Preparedness

Now writing the full study note.


Update on Immunization Programme and Pandemic Preparedness

1. At a Glance

2. Why in the News

3. Background & Evolution

4. Core Static Facts

Item Detail
Nodal Ministry Ministry of Health and Family Welfare (MoHFW) [S1]
National FIC coverage >90% sustained 4 years: 94.7% (2022-23), 93.7% (2023-24), 98.3% (2024-25), 97.9% (2025-26) [S1]
Policy basis National Health Policy, 2017 [S1]
HPV campaign launch 28 February 2026, Ajmer, Rajasthan, by PM Modi [S3]
HPV target group ~1.2 crore girls aged 14 (per PIB 21 July release) / ~1.15 crore per launch-day release, across all 36 States/UTs, free at government facilities [S1][S3]
HPV delivery mode School-based, grade 5th–10th; health facilities/mobile/community outreach for out-of-school girls [S3]
Advisory body NTAGI (National Technical Advisory Group on Immunization) [S3]
ICMR diagnostic network 160+ Virus Research and Diagnostic Laboratories (VRDLs) [S1]
New training module Integrated Training Module for Primary Healthcare Team at Ayushman Arogya Mandir, launched April 2026; covers Medical Officers, Staff Nurses, CHOs, ANMs, ASHAs [S1]
Pandemic-preparedness schemes PM-ABHIM (infra), IDSP (surveillance, Rapid Response Teams) [S1]
Surveillance/IT platforms IHIP, IDSP portal, HMIS, AAM Portal, NP-NCD Portal [S1]
International framework WHO PRET initiative; IHR (2005); WHO SEAR Roadmap 2023–2027 (target: 2031) [S4]

5. Multi-Dimensional Analysis

Social - HPV vaccination targets adolescent girls specifically — a gender-and-health-equity intervention against cervical cancer, India's second most common cancer among women [S3]. - School-based delivery mechanism improves reach into rural/low-literacy households where awareness of cervical cancer prevention is weak [S3].

Administrative - Delivery spans Centre (NTAGI recommendation, MoHFW funding), States/UTs (implementation across all 36), and grassroots workers (ASHAs, ANMs, CHOs) — a federal implementation test case [S1][S3]. - Coordination challenge: reaching out-of-school girls via mobile/community outreach teams, a known gap area in adolescent health schemes [S3].

Scientific/Technological - ICMR's 160+ VRDL network provides decentralized genomic/pathogen diagnostic capacity — critical lesson learnt from COVID-19 testing bottlenecks [S1]. - Integrated digital platforms (IHIP, HMIS, AAM Portal) reflect a push toward real-time, data-driven disease surveillance [S1].

Governance/Ethical - Sustained >90% FIC for four years is presented as an achievement, but bulletin-style reporting (written Parliament reply) invites scrutiny on state-wise disaggregation, urban-rural gaps, and dropout rates, which are not detailed in the release [S1]. - Free-of-cost delivery addresses equity but raises questions on consent/parental awareness for a vaccine targeting minors [S3].

Geopolitical/Strategic - India's HPV rollout aligns it with WHO's global cervical cancer elimination push and the 160+ nations already vaccinating [S3]. - PRET framework reflects India's integration into WHO's global health-security architecture ahead of future pandemics [S4].

6. Recent Developments (last 12–18 months)

7. Prelims Hooks

8. Mains Relevance

9. Related Topics to Study Next

10. Common Errors / Trap Areas

11. Sources